Cancer Therapy News and Research

RSS

Study provides insight into regenerative potential of prostate gland

The standard treatment for men with advanced prostate cancer is androgen-deprivation therapy. Androgens are hormones that fuel prostate cell growth; removing them with either drugs or surgery causes the prostate gland to shrink by 90%.

30 Apr 2020

Changes to gut microbiome could improve cancer outcomes for smokers

Changes to the gut microbiome interacted with the immune system to slow the growth of cancer in mice exposed to cigarette smoke, according to research that was selected for presentation at Digestive Disease Week 2020.

30 Apr 2020

SU2C commends FDA’s approval of new cancer therapy

Stand Up To Cancer (SU2C) welcomed the recent Food and Drug Administration (FDA) approval this month of encorafenib in combination with cetuximab for patients with advanced BRAF-mutated colorectal cancer.

30 Apr 2020

Damon Runyon offers extension awards to help scientists affected by COVID-19 crisis

COVID-19 related laboratory shutdowns present a serious threat to scientists in the critical earliest stages of their careers.

28 Apr 2020

Simple blood test offers early warning of chemotherapy-related cardiac dysfunction

Scientists have identified a collection of biomarkers that together signal that a person's cancer treatment may be harming their heart.

27 Apr 2020

Patients with aggressive form of skin cancer can benefit from new type of immunotherapy

In what is believed to be a first-of-its-kind study to evaluate the safety of a type of immunotherapy before surgery in patients with an aggressive form of skin cancer, researchers report that the treatment eliminated pathologic evidence of cancer in nearly half of the study participants undergoing surgery.

27 Apr 2020

Investigational drug may hold benefit for patients with lung and ovarian cancers

In a first-time disclosure of IPN60090, a small-molecule inhibitor of the metabolic enzyme glutaminase (GLS1), researchers from The University of Texas MD Anderson Cancer Center's Therapeutics Discovery division and Ipsen Biopharmaceuticals reported the preclinical discovery and early-stage clinical development of this novel drug. IPN60090, now under investigation in a Phase I trial, may hold benefit for certain patients with lung and ovarian cancers.

27 Apr 2020

Study: Artificial intelligence strategy can assess and categorize indeterminate pulmonary nodules

Computed tomography scans for people at risk for lung cancer lead to earlier diagnoses and improve survival rates, but they can also lead to overtreatment when suspicious nodules turn out to be benign.

24 Apr 2020

Therapeutic antibody successfully prevents metastases in mice with breast or lung cancer

A receptor in the cell layer that lines the blood vessels from the inside stimulates both the formation of new blood vessels in tumors and metastasis.

24 Apr 2020

Graphene-based nanomedicine enables targeted cancer treatment at molecular level

"Three" kinds of regalia such as crown, orb, and sward are often necessary to be a high king for conquering the world. For fighting off cancerous diseases, what do we need? This "triple" chemical modified nanomaterial might be save the patient.

23 Apr 2020

Bayreuth researchers discover natural protective mechanism against cancer

Susanne Hellmuth and Olaf Stemmann from the Chair of Genetics at the University of Bayreuth have discovered a natural protective mechanism that leads to the programmed death of potentially diseased cells.

23 Apr 2020

A faster and easier treatment option to prevent blindness in preterm infants

Babies born prematurely who require treatment to prevent blindness from retinopathy of prematurity (ROP) could be treated with a dose of Avastin (bevacizumab) that is a fraction of the dose commonly used for ROP currently.

23 Apr 2020

Higher levels of specific gene can indicate better prognosis in prostate cancer

The most common form of cancer in older men is prostate cancer. In many cases the tumor grows slowly and can be treated effectively, but it is sometimes more aggressive and becomes terminal.

23 Apr 2020

Researchers are exploring potential therapy for controlling infectious diseases

The engineering of specific virus-targeting receptors onto a patient's own immune cells is now being explored by scientists from Duke-NUS Medical School (Duke-NUS), as a potential therapy for controlling infectious diseases, including the COVID-19-causing virus, SARS-CoV-2.

22 Apr 2020

COVID-19 and immunodeficiency

COVID-19 disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a highly infectious disease. As of today, over 170,000 people worldwide have succumbed to the infection. Reports have shown that some comorbidities and illnesses raise the risk of getting infected and also influence the severity of the disease. Having a compromised immune system can also drastically raise the risk of getting COVID-19.

21 Apr 2020

Cancer Research UK calls for mass Covid-19 testing to prevent unnecessary cancer deaths

Thousands of cancer patients in the UK have had their treatment stopped or delayed because of COVID-19, and with pressures mounting on the health service, Cancer Research UK calls for widespread testing to prevent unnecessary cancer deaths.*

17 Apr 2020

Gold-containing drug auranofin kills 95% of SARS-CoV-2 virus in 48 hours in lab conditions

A drug called auranofin, approved for the treatment of rheumatoid arthritis, effectively inhibits severe acute respiratory syndrome coronavirus (SARS-CoV-2) in laboratory conditions, as described in a new study by Georgia State University researchers.

16 Apr 2020

Cancer Therapy News and Research

Study provides insight into regenerative potential of prostate gland

Changes to gut microbiome could improve cancer outcomes for smokers

SU2C commends FDA’s approval of new cancer therapy

Damon Runyon offers extension awards to help scientists affected by COVID-19 crisis

Simple blood test offers early warning of chemotherapy-related cardiac dysfunction

Patients with aggressive form of skin cancer can benefit from new type of immunotherapy

Investigational drug may hold benefit for patients with lung and ovarian cancers

Study: Artificial intelligence strategy can assess and categorize indeterminate pulmonary nodules

Therapeutic antibody successfully prevents metastases in mice with breast or lung cancer

Graphene-based nanomedicine enables targeted cancer treatment at molecular level

Bayreuth researchers discover natural protective mechanism against cancer

A faster and easier treatment option to prevent blindness in preterm infants

Higher levels of specific gene can indicate better prognosis in prostate cancer

Researchers are exploring potential therapy for controlling infectious diseases

COVID-19 and immunodeficiency

Cancer Research UK calls for mass Covid-19 testing to prevent unnecessary cancer deaths

Gold-containing drug auranofin kills 95% of SARS-CoV-2 virus in 48 hours in lab conditions

New therapeutic approach for preserving inflammation-free phases of Crohn's disease

Chronic stress can influence the efficacy of radiation therapy, study suggests

Harnessing power of cancer gene could lead to first curative treatment for heart disease

Your guide to microplate readers for cancer research eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News